Vericel Corp Net Worth
Vericel Corp Net Worth Breakdown | VCEL |
Vericel Corp Net Worth Analysis
Vericel Corp's net worth analysis, or its valuation, is the process of determining the total value of the company. This involves assessing a range of factors, including Vericel Corp's financial performance, assets, liabilities, and potential for growth. The ultimate goal is to provide a clear understanding of Vericel Corp's overall worth, which can help investors make informed investment decisions. There are several methods that can be used to perform Vericel Corp's net worth analysis. One common approach is to calculate Vericel Corp's market capitalization.Another approach is to use the price-to-earnings ratio (P/E ratio), which compares Vericel Corp's stock price to its earnings per share (EPS). Discounted cash flow (DCF) analysis is another popular method for assessing Vericel Corp's net worth. This approach calculates the present value of Vericel Corp's future cash flows, taking into account factors such as growth rate, profitability, and risk. By comparing the present value of Vericel Corp's cash flows to its current stock price, investors can gain a better understanding of the company's overall value. Finally, investors may use comparable company analysis to evaluate Vericel Corp's net worth. This involves comparing Vericel Corp's financial metrics to similar companies in the same industry. By identifying companies with similar financial characteristics, investors can gain insight into Vericel Corp's net worth relative to its peers.
Enterprise Value |
|
To determine if Vericel Corp is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Vericel Corp's net worth research are outlined below:
| Vericel Corp Ord generated a negative expected return over the last 90 days | |
| Over 99.0% of the company outstanding shares are owned by institutional investors | |
| Latest headline from thelincolnianonline.com: Vericel Corporation Shares Purchased by Valeo Financial Advisors LLC |
Vericel Corp uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in Vericel Corp Ord. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Vericel Corp's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 22nd of February 2024 Upcoming Quarterly Report | View | |
| 8th of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 22nd of February 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Vericel Corp Target Price Consensus
Vericel target price is determined by taking all analyst projections and averaging them out. There is no one specific way to measure analysts' performance other than comparing it to past results via a very sophisticated attribution analysis. Vericel Corp's target price projections below should be used in combination with other traditional price prediction techniques such as stock price forecasting, investor sentiment analysis, technical analysis, earnings estimate, and various momentum models.
| 8 | Strong Buy |
Most Vericel analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to help potential investors understand Vericel stock's fair price compared to its market value. Analysts arrive at stock ratings after researching the public financial statements of Vericel Corp Ord, talking to its executives and customers, or listening to those companies' conference calls.
Macroaxis Advice Exposure ValuationVericel Corp Target Price Projection
Vericel Corp's current and average target prices are 39.82 and 59.38, respectively. The current price of Vericel Corp is the price at which Vericel Corp Ord is currently trading. On the other hand, Vericel Corp's target price is what analysts think the stock is worth or could sell for in the future. The more significant the discrepancy between the two prices, the more it stimulates investors to act.Current Price
Vericel Corp Market Quote on 16th of July 2025
Target Price
Analyst Consensus On Vericel Corp Target Price
Know Vericel Corp's Top Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Vericel Corp is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Vericel Corp Ord backward and forwards among themselves. Vericel Corp's institutional investor refers to the entity that pools money to purchase Vericel Corp's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | William Blair Investment Management, Llc | 2025-03-31 | 1.3 M | Geode Capital Management, Llc | 2025-03-31 | 1.2 M | Federated Hermes Inc | 2025-03-31 | 1.2 M | Bnp Paribas Investment Partners Sa | 2025-03-31 | 1.2 M | Loomis, Sayles & Company Lp | 2025-03-31 | 1.1 M | Royal Bank Of Canada | 2025-03-31 | 950.5 K | New York State Common Retirement Fund | 2025-03-31 | 862.3 K | Dimensional Fund Advisors, Inc. | 2025-03-31 | 767.4 K | Macquarie Group Ltd | 2025-03-31 | 662.9 K | Blackrock Inc | 2025-03-31 | 8 M | Vanguard Group Inc | 2025-03-31 | 3.5 M |
Follow Vericel Corp's market capitalization trends
The company currently falls under 'Mid-Cap' category with a current market capitalization of 2.01 B.Market Cap |
|
Project Vericel Corp's profitablity
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | 0.02 | 0.03 | |
| Return On Capital Employed | 0.01 | 0.01 | |
| Return On Assets | 0.02 | 0.03 | |
| Return On Equity | 0.04 | 0.04 |
When accessing Vericel Corp's net worth, it's important to look at multiple sources and consider different scenarios. For example, gross profit margin measures Vericel Corp's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of Vericel Corp's profitability and make more informed investment decisions.
Evaluate Vericel Corp's management efficiency
Return On Tangible Assets is expected to rise to 0.03 this year. Return On Capital Employed is expected to rise to 0.01 this year. At this time, Vericel Corp's Intangible Assets are quite stable compared to the past year. Return On Tangible Assets is expected to rise to 0.03 this year, although the value of Non Currrent Assets Other will most likely fall to about 528.2 K. Vericel Corp's management efficiency ratios could be used to measure how well Vericel Corp manages its routine affairs as well as how well it operates its assets and liabilities.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | 5.98 | 5.68 | |
| Tangible Book Value Per Share | 5.85 | 5.56 | |
| Enterprise Value Over EBITDA | 162.77 | 170.91 | |
| Price Book Value Ratio | 9.19 | 9.65 | |
| Enterprise Value Multiple | 162.77 | 170.91 | |
| Price Fair Value | 9.19 | 9.65 | |
| Enterprise Value | 1.6 B | 1.7 B |
Vericel Corp Ord benefits from a proactive management team that anticipates market trends. Our analysis delves into how this proactive stance influences financial metrics and stock valuation.
Enterprise Value Revenue 8.3454 | Revenue | Quarterly Revenue Growth 0.026 | Revenue Per Share | Return On Equity |
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Vericel Corp insiders, such as employees or executives, is commonly permitted as long as it does not rely on Vericel Corp's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Vericel Corp insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Vericel Corp Corporate Filings
F4 | 4th of June 2025 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
| 15th of May 2025 Other Reports | ViewVerify | |
8K | 8th of May 2025 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
| 20th of March 2025 Other Reports | ViewVerify |
Vericel Corp Earnings Estimation Breakdown
The calculation of Vericel Corp's earning per share is based on the data from the past 12 consecutive months, used for reporting the company's financial figures. The next projected EPS of Vericel Corp is estimated to be 0.0575 with the future projection ranging from a low of 0.0225 to a high of 0.0925. Please be aware that this consensus of annual earnings estimates for Vericel Corp Ord is based on EPS before non-recurring items and includes expenses related to employee stock options.Last Reported EPS
0.02 Lowest | Expected EPS | 0.09 Highest |
Vericel Corp Earnings Projection Consensus
Suppose the current estimates of Vericel Corp's value are higher than the current market price of the Vericel Corp stock. In this case, investors may conclude that Vericel Corp is overpriced and will exhibit bullish sentiment. On the other hand, if the present value is lower than the stock price, analysts may conclude that the market undervalues the equity. These scenarios may suggest that the market is not as efficient as it should be at the estimation time, and Vericel Corp's stock will quickly adjusts to the new information provided by the consensus estimate.
| Number of Analysts | Historical Accuracy | Last Reported EPS | Estimated EPS for 31st of December 2025 | Current EPS (TTM) | |
| 8 | 54.56% | 0.0 | 0.0575 | 0.05 |
Vericel Corp Earnings per Share Projection vs Actual
Actual Earning per Share of Vericel Corp refers to what the company shows during its earnings calls or quarterly reports. The Expected EPS is what analysts covering Vericel Corp Ord predict the company's earnings will be in the future. The higher the earnings per share of Vericel Corp, the better is its profitability. While calculating the Earning per Share, we use the weighted ratio, as the number of shares outstanding can change over time.Vericel Corp Estimated Months Earnings per Share
For an investor who is primarily interested in generating an income out of investing in entities such as Vericel Corp, the EPS ratio can tell if the company is intending to increase its current dividend. Although EPS is an essential tool for investors, it should not be used in isolation. EPS of Vericel Corp should always be considered in relation to other companies to make a more educated investment decision.Vericel Quarterly Analyst Estimates and Surprise Metrics
Earnings surprises can significantly impact Vericel Corp's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
null | null | null | null | null | 0 | ||
null | null | null | null | null | 0 | ||
2025-05-06 | 2025-03-31 | -0.1533 | -0.23 | -0.0767 | 50 | ||
2025-02-26 | 2024-12-31 | 0.34 | 0.38 | 0.04 | 11 | ||
2024-11-07 | 2024-09-30 | -0.05 | -0.02 | 0.03 | 60 | ||
2024-08-01 | 2024-06-30 | -0.08 | -0.1 | -0.02 | 25 | ||
2024-05-08 | 2024-03-31 | -0.11 | -0.08 | 0.03 | 27 | ||
2024-02-29 | 2023-12-31 | 0.17 | 0.26 | 0.09 | 52 | ||
2023-11-08 | 2023-09-30 | -0.12 | -0.08 | 0.04 | 33 | ||
2023-08-02 | 2023-06-30 | -0.15 | -0.11 | 0.04 | 26 | ||
2023-05-10 | 2023-03-31 | -0.15 | -0.16 | -0.01 | 6 | ||
2023-02-23 | 2022-12-31 | 0.04 | 0.12 | 0.08 | 200 | ||
2022-11-09 | 2022-09-30 | -0.1 | -0.14 | -0.04 | 40 | ||
2022-08-03 | 2022-06-30 | -0.12 | -0.19 | -0.07 | 58 | ||
2022-05-04 | 2022-03-31 | -0.12 | -0.15 | -0.03 | 25 | ||
2022-02-24 | 2021-12-31 | 0.14 | 0.09 | -0.05 | 35 | ||
2021-11-09 | 2021-09-30 | -0.03 | -0.11 | -0.08 | 266 | ||
2021-08-04 | 2021-06-30 | -0.08 | -0.08 | 0.0 | 0 | ||
2021-05-05 | 2021-03-31 | -0.04 | -0.07 | -0.03 | 75 | ||
2021-02-24 | 2020-12-31 | 0.2 | 0.25 | 0.05 | 25 | ||
2020-11-05 | 2020-09-30 | -0.02 | 0.08 | 0.1 | 500 | ||
2020-08-05 | 2020-06-30 | -0.21 | -0.18 | 0.03 | 14 | ||
2020-05-05 | 2020-03-31 | -0.08 | -0.1 | -0.02 | 25 | ||
2020-02-25 | 2019-12-31 | 0.2 | 0.2 | 0.0 | 0 | ||
2019-11-05 | 2019-09-30 | -0.02 | 0.07 | 0.09 | 450 | ||
2019-08-06 | 2019-06-30 | -0.46 | -0.05 | 0.41 | 89 | ||
2019-05-07 | 2019-03-31 | -0.07 | -0.07 | 0.0 | 0 | ||
2019-02-26 | 2018-12-31 | 0.04 | 0.13 | 0.09 | 225 | ||
2018-11-06 | 2018-09-30 | -0.11 | -0.02 | 0.09 | 81 | ||
2018-08-06 | 2018-06-30 | -0.12 | -0.12 | 0.0 | 0 | ||
2018-05-08 | 2018-03-31 | -0.13 | -0.21 | -0.08 | 61 | ||
2018-03-05 | 2017-12-31 | -0.07 | 0.03 | 0.1 | 142 | ||
2017-11-07 | 2017-09-30 | -0.16 | -0.16 | 0.0 | 0 | ||
2017-08-09 | 2017-06-30 | -0.19 | -0.07 | 0.12 | 63 | ||
2017-05-10 | 2017-03-31 | -0.14 | -0.31 | -0.17 | 121 | ||
2017-03-10 | 2016-12-31 | -0.18 | -0.23 | -0.05 | 27 | ||
2016-11-07 | 2016-09-30 | -0.28 | -0.38 | -0.1 | 35 | ||
2016-08-08 | 2016-06-30 | -0.15 | -0.22 | -0.07 | 46 | ||
2016-05-10 | 2016-03-31 | -0.24 | -0.08 | 0.16 | 66 | ||
2016-03-14 | 2015-12-31 | -0.14 | -0.02 | 0.12 | 85 | ||
2015-11-13 | 2015-09-30 | -0.24 | -0.26 | -0.02 | 8 | ||
2015-08-12 | 2015-06-30 | -0.2 | -0.16 | 0.04 | 20 | ||
2015-05-14 | 2015-03-31 | -0.21 | -0.27 | -0.06 | 28 | ||
2015-03-23 | 2014-12-31 | -0.46 | -0.17 | 0.29 | 63 | ||
2014-11-13 | 2014-09-30 | -0.66 | -0.52 | 0.14 | 21 | ||
2014-08-14 | 2014-06-30 | -1.02 | -1.0 | 0.02 | 1 | ||
2014-05-15 | 2014-03-31 | -0.92 | -1.26 | -0.34 | 36 | ||
2014-03-13 | 2013-12-31 | -1.33 | -0.97 | 0.36 | 27 | ||
2013-11-12 | 2013-09-30 | -2.02 | -0.06 | 1.96 | 97 | ||
2013-08-07 | 2013-06-30 | -2.8 | -2.2 | 0.6 | 21 | ||
2013-05-08 | 2013-03-31 | -3.8 | -3.0 | 0.8 | 21 | ||
2013-03-18 | 2012-12-31 | -4.54 | -3.6 | 0.94 | 20 | ||
2012-11-08 | 2012-09-30 | -4.67 | -3.4 | 1.27 | 27 | ||
2012-08-07 | 2012-06-30 | -4.83 | -4.4 | 0.43 | 8 | ||
2012-05-10 | 2012-03-31 | -4 | -5.0 | -1.0 | 25 | ||
2012-03-12 | 2011-12-31 | -4.6 | -1.4 | 3.2 | 69 | ||
2011-11-08 | 2011-09-30 | -4.03 | -1.0 | 3.03 | 75 | ||
2011-08-15 | 2011-06-30 | -3.45 | -5.2 | -1.75 | 50 | ||
2011-05-16 | 2011-03-31 | -3.6 | -2.6 | 1.0 | 27 | ||
2011-02-28 | 2010-12-31 | -3.35 | -8.8 | -5.45 | 162 | ||
2010-11-08 | 2010-09-30 | -3.55 | -4.2 | -0.65 | 18 | ||
2010-08-17 | 2010-06-30 | -2.9 | -3.6 | -0.7 | 24 | ||
2008-08-29 | 2008-06-30 | -6.4 | -6.4 | 0.0 | 0 | ||
2008-05-12 | 2008-03-31 | -6.93 | -6.4 | 0.53 | 7 | ||
2008-02-08 | 2007-12-31 | -6.4 | -6.4 | 0.0 | 0 | ||
2007-11-09 | 2007-09-30 | -6.4 | -6.4 | 0.0 | 0 | ||
2007-09-10 | 2007-06-30 | -6.4 | -6.4 | 0.0 | 0 | ||
2007-05-08 | 2007-03-31 | -6.4 | -6.4 | 0.0 | 0 | ||
2007-02-07 | 2006-12-31 | -6.4 | -6.4 | 0.0 | 0 | ||
2006-11-09 | 2006-09-30 | -6.4 | -4.8 | 1.6 | 25 | ||
2006-09-13 | 2006-06-30 | -5.87 | -6.4 | -0.53 | 9 | ||
2006-05-10 | 2006-03-31 | -6.93 | -6.4 | 0.53 | 7 | ||
2006-02-08 | 2005-12-31 | -6.4 | -6.4 | 0.0 | 0 | ||
2005-11-09 | 2005-09-30 | -5.87 | -4.8 | 1.07 | 18 | ||
2005-09-08 | 2005-06-30 | -5.6 | -4.8 | 0.8 | 14 | ||
2005-05-06 | 2005-03-31 | -4.8 | -4.8 | 0.0 | 0 |
Vericel Corp Corporate Management
| Mike Gilligan | Senior Sales | Profile | |
| Patrick Fowler | Senior Strategy | Profile | |
| Sean Flynn | Chief Officer | Profile | |
| MB FRCSEd | Chief Officer | Profile | |
| Roland DeAngelis | Senior Operations | Profile | |
| Karen Mahoney | Chief Officer | Profile | |
| Heidi Hassen | Senior Resources | Profile |
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Vericel Corp Ord. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income. You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Vericel Corp. If investors know Vericel will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Vericel Corp listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.476 | Earnings Share 0.05 | Revenue Per Share | Quarterly Revenue Growth 0.026 | Return On Assets |
The market value of Vericel Corp Ord is measured differently than its book value, which is the value of Vericel that is recorded on the company's balance sheet. Investors also form their own opinion of Vericel Corp's value that differs from its market value or its book value, called intrinsic value, which is Vericel Corp's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Vericel Corp's market value can be influenced by many factors that don't directly affect Vericel Corp's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Vericel Corp's value and its price as these two are different measures arrived at by different means. Investors typically determine if Vericel Corp is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Vericel Corp's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.